Skip to main content

Table 3 Correlation among apoptotic markers, disease activity, and levels of autoantibodies in lupus patients

From: The association among leukocyte apoptosis, autoantibodies and disease severity in systemic lupus erythematosus

  

SLEDAI2k

c3

c4

a-ro

a-ro52

a-ro60

a-la

a-mi2

(7AAD + annexinV) of WBC (%)

r

0.14

-0.3

-0.19

.513*

0.29

0.41

.439*

.492*

p value

0.54

0.17

0.39

0.01

0.17

0.05

0.04

0.02

(7AAD + annexinV) of Granulocyte (%)

r

0.18

-.460*

-0.2

0.33

0.2

0.32

0.33

0.3

p value

0.42

0.03

0.37

0.13

0.36

0.13

0.13

0.16

(7AAD + annexinV) of CD8 (+)(%)

r

-0.06

0.35

.636*

-0.07

0.07

-0.21

-0.09

-0.11

p value

0.87

0.33

0.04

0.85

0.85

0.57

0.8

0.77

APO2.7 of CD4(+)(%)

r

0.3

0.17

0.05

-.684*

-.717*

-0.62

-0.57

-0.24

p value

0.43

0.67

0.9

0.04

0.03

0.08

0.11

0.54

APO2.7 of CD19 (+)(%)

r

.793*

-0.45

-0.48

0.32

0.34

0.29

0.4

-0.07

p value

0.01

0.22

0.19

0.4

0.37

0.45

0.28

0.86

SLEDAI2k

r

X

-0.35

-.508*

0.3

0.23

.407*

0.24

0.21

 

p value

 

0.1

0.01

0.15

0.29

0.05

0.25

0.32

  1. Note: *, p<0.05.
  2. Abbreviations: R Correlation coefficient, A-ro Anti-Ro52/60, A-ro52 Anti-Ro 52 kDa, A-ro60 Anti-Ro 60 kDa, A-la Anti-La, A-mi2 Anti-Mi-2, WBC White blood cells or leukocytes, 7-AAD 7-amino-actinomycin D, SLEDAI-2 K Systemic lupus erythematosus disease activity index 2000.